nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer
|
Mertens, Laura S |
|
|
25 |
2 |
p. 156-157 |
artikel |
2 |
Accelerating progress on EU cancer control
|
Charalambous, Andreas |
|
|
25 |
2 |
p. 158-160 |
artikel |
3 |
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
|
Sathekge, Mike M |
|
|
25 |
2 |
p. 175-183 |
artikel |
4 |
2023 ASH annual meeting
|
Cookson, Emma |
|
|
25 |
2 |
p. 161 |
artikel |
5 |
Cancer care and treatment during homelessness
|
Asgary, Ramin |
|
|
25 |
2 |
p. e84-e90 |
artikel |
6 |
Cancer misinformation puts patients in harm's way
|
Furlow, Bryant |
|
|
25 |
2 |
p. 165-166 |
artikel |
7 |
Classifying and grading liposarcoma by CT
|
Sanomachi, Tomomi |
|
|
25 |
2 |
p. e53 |
artikel |
8 |
Correction to Lancet Oncol 2020; 21: 796–807
|
|
|
|
25 |
2 |
p. e61 |
artikel |
9 |
Correction to Lancet Oncol 2023; 24: 1018–28
|
|
|
|
25 |
2 |
p. e61 |
artikel |
10 |
Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis
|
Abu Awwad, Dania |
|
|
25 |
2 |
p. 225-234 |
artikel |
11 |
Cutaneous blisters mimicking bullous pemphigoid
|
Yu, Yue-Qian |
|
|
25 |
2 |
p. e91 |
artikel |
12 |
Developing therapies for triple-negative breast cancer subtypes
|
Okines, Alicia |
|
|
25 |
2 |
p. 149-151 |
artikel |
13 |
Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial
|
Armenian, Saro H |
|
|
25 |
2 |
p. 235-245 |
artikel |
14 |
Expression of concern—Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
|
The Editors of The Lancet Oncology, |
|
|
25 |
2 |
p. e42 |
artikel |
15 |
High health expenses in the WHO Western Pacific region
|
Das, Manjulika |
|
|
25 |
2 |
p. 162 |
artikel |
16 |
Immunotherapy: balancing the risks and benefits
|
The Lancet Oncology, |
|
|
25 |
2 |
p. 147 |
artikel |
17 |
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations
|
Meattini, Icro |
|
|
25 |
2 |
p. e73-e83 |
artikel |
18 |
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
|
Bajpai, Jyoti |
|
|
25 |
2 |
p. 246-254 |
artikel |
19 |
Modelling radiotherapy availability in the Asia-Pacific region
|
Lievens, Yolande |
|
|
25 |
2 |
p. 152-154 |
artikel |
20 |
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
|
Frei, Anja L |
|
|
25 |
2 |
p. 198-211 |
artikel |
21 |
Multiplex immunofluorescence for tumour immune biomarker discovery
|
Väyrynen, Juha P |
|
|
25 |
2 |
p. 151-152 |
artikel |
22 |
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
|
Shitara, Kohei |
|
|
25 |
2 |
p. 212-224 |
artikel |
23 |
Nigerian competition watchdog fines British American Tobacco
|
Burki, Talha |
|
|
25 |
2 |
p. 164 |
artikel |
24 |
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
|
Fan, Lei |
|
|
25 |
2 |
p. 184-197 |
artikel |
25 |
Pembrolizumab plus chemotherapy for advanced gastric cancer
|
Huang, Chen-yu |
|
|
25 |
2 |
p. e50 |
artikel |
26 |
Pembrolizumab plus chemotherapy for advanced gastric cancer
|
Schutte, Tim |
|
|
25 |
2 |
p. e51 |
artikel |
27 |
Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply
|
Rha, Sun Young |
|
|
25 |
2 |
p. e52 |
artikel |
28 |
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
|
Pfister, Christian |
|
|
25 |
2 |
p. 255-264 |
artikel |
29 |
Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns
|
Wallace, William Hamish B |
|
|
25 |
2 |
p. e57 |
artikel |
30 |
Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns
|
Zheng, Fangjieyi |
|
|
25 |
2 |
p. e58 |
artikel |
31 |
Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns – Authors' reply
|
Im, Cindy |
|
|
25 |
2 |
p. e59-e60 |
artikel |
32 |
Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study
|
McLeod, Megan |
|
|
25 |
2 |
p. e63-e72 |
artikel |
33 |
Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors
|
Leerink, Jan M |
|
|
25 |
2 |
p. 154-156 |
artikel |
34 |
Sub-Saharan Africa's harmonised cancer guidelines
|
Makoni, Munyaradzi |
|
|
25 |
2 |
p. 163 |
artikel |
35 |
Targeted alpha therapy: a new tool for advanced prostate cancer
|
Kairemo, Kalevi |
|
|
25 |
2 |
p. 148-149 |
artikel |
36 |
Thank you to The Lancet Oncology's reviewers in 2023
|
The Lancet Oncology Editors, |
|
|
25 |
2 |
p. e43-e49 |
artikel |
37 |
The GLOW trial in chronic lymphocytic leukaemia
|
Fey, Martin |
|
|
25 |
2 |
p. e54 |
artikel |
38 |
The GLOW trial in chronic lymphocytic leukaemia
|
van Gelder, Michel |
|
|
25 |
2 |
p. e55 |
artikel |
39 |
The GLOW trial in chronic lymphocytic leukaemia – Authors' reply
|
Niemann, Carsten U |
|
|
25 |
2 |
p. e56 |
artikel |
40 |
Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
|
Gyawali, Bishal |
|
|
25 |
2 |
p. 167-170 |
artikel |
41 |
US radiation oncology organisations work towards Medicare payment reform
|
Das, Manjulika |
|
|
25 |
2 |
p. e62 |
artikel |
42 |
World Oncology Forum amplifies its appeal in global fight against cancer
|
Cavalli, Franco |
|
|
25 |
2 |
p. 170-174 |
artikel |